Head and neck squamous cell carcinoma cell lines: Established models and rationale for selection

Head and Neck

Volumn 29, Issue 2, 2007, Pages 163-188

  Lin, Charles J ^a   Grandis, Jennifer R ^a   Carey, Thomas E ^b   Gollin, Susanne M ^a,c   Whiteside, Theresa L ^a   Koch, Wayne M ^d   Ferris, Robert L ^a   Lai, Stephen Y ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cell line; Characteristics; Head and neck cancer; HNSCC; SCCHN

Indexed keywords

CANCER CELL CULTURE; CANCER MODEL; CELL GROWTH; CELL LINE; HEAD AND NECK CARCINOMA; HUMAN; MEDICAL LITERATURE; PRIORITY JOURNAL; REVIEW; SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; HEAD AND NECK NEOPLASMS; HUMANS; MODELS, BIOLOGICAL; TRANSPLANTATION, HETEROLOGOUS;

EID: 33846546485     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.20478     Document Type: Review

References (95)

1. Stewart BW, Kleihues P, editors. Cancer facts & figures. In World Health Organization: World cancer report. London: IACR Press; 2003.
2. Jemal A, Murray T, Ward E, et al. Cancer statistics, 2005. CA Cancer J Clin 2005;55:10-30.
3. Batsakis J. Tumors of the head and neck. Baltimore: Williams and Wilkins; 1979.
4. Dimery IW, Hong WK. Overview of combined modality therapies for head and neck cancer. J Natl Cancer Inst 1993;85:95-111.
5. Vikram B. Failure at distant sites following multimodality treatment for advanced head and neck cancer. Head Neck Surg 1984;6:730-733.
6. Freshney RI. Culture of animal cells, 3rd ed. New York: Wiley-Liss; 1994. pp 1-7.
7. Moore A, Sabachewsky L, Toolan H. Culture characteristics of four permanent lines of human cancer cells. Cancer Res 1955;15:598-602.
8. Easty D, Easty G, Carter R, Monaghan P, Butler L. Ten human carcinoma cell lines derived from squamous carcinomas of the head and neck. Br J Cancer 1981;43:772-785.
9. Rheinwald J, Beckett M. Tumorigenic keratinocyte lines requiring anchorage and fibroblast support cultured from human squamous cell carcinomas. Cancer Res 1981;41:1657-1663.
10. Edwards P, Easty D, Foster C. Selective culture of epithelioid cells from a human squamous carcinoma using a monoclonal antibody to kill fibroblasts. Cell Biol Int Rep 1980;4:917-922.
11. Krause C, Carey T, Ott R, Hurbis C, McClatchey K, Regezi J. Human squamous cell carcinoma. Establishment and characterization of new permanent cell lines. Arch Otolaryngol 1981;107:703-710.
12. Brattain MG, Willson J, Kolerba A, Patil S, Venkateswarlu S. Colorectal cancer. In: Masters JR, Palsson B, editors. Human cell culture, Vol 2, cancer cell lines, Part 2. Norwell: Kluwer Academic Publishers; 2002. pp 293-304.
13. Kozlowshi J, Sensibar JA. Prostate cancer. In: Masters JR, Palsson B, editors. Human cell culture, Vol 2, cancer cell lines, Part 2. Norwell: Kluwer Academic Publishers; 2002. pp 305-332.
14. Sutherland R, Watts CK, Lee CS, Musgrove EA. Breast cancer. In: Masters JR, Palsson B, editors. Human cell culture, Vol 2, cancer cell lines, Part 2. Norwell: Kluwer Academic Publishers; 2002. pp 79-106.
15. Carey T. Head and neck tumor cell lines. In: Hay RKM, Park JG, Gazdar A, editors. Atlas of human tumor cell lines. Orlando: Academic Press. 1994. pp 79-120.
16. Lansford C, Grenman R, Bier H, et al. Head and neck cancers. In: Masters JR, Palsson B, editors. Human cell culture, Vol 2, cancer cell lines, Part 2. Dordrecht: Kluwer Academic Press; 1999. pp 185-255.
17. Butler M. Supplements to basal media. In: Butler M, Dawson M, editors. Cell culture. Oxford: Academic Press; 1992. pp 107-134.
18. Langdon S. Basic principles of cancer cell culture. In: Langdon S, editor. Cancer cell culture: methods and protocols. Totowa: Humana Press; 2004. pp 3-15.
19. Barile MF, Rottem S. Mycoplasmes in cell culture. In: Kahani I, Adoni A, editors. Rapid diagnosis of mycoplasmas. New York: Plenum; 1993. pp 155-193.
20. Uphoff C, Drexler H. Elimination of mycoplasma from infected cell lines using antibiotics. Totowa: Humana Press; 2004. pp 327-334.
21. Blot WJ, McLaughlin JK, Winn DM, et al. Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res 1988;48:3282-3287.
22. Franceschi S, Talamini R, Barra S, et al. Smoking and drinking in relation to cancers of the oral cavity, pharynx, larynx, and esophagus in northern Italy. Cancer Res 1990;50:6502-6507.
23. Sacks PG, Parnes SM, Gallick GE, et al. Establishment and characterization of two new squamous cell carcinoma cell lines derived from tumors of the head and neck. Cancer Res 1988;48:2858-2866.
24. Whang-Peng J, Banks-Schlegel SP, Lee EC. Cytogenetic studies of esophageal carcinoma cell lines. Cancer Genet Cytogenet 1990;45:101-120.
25. Latif F, Fivash M, Glenn G, et al. Chromosome 3p deletions in head and neck carcinomas: statistical ascertainment of allelic loss. Cancer Res 1992;52:1451-1456.
26. Heo DS, Snyderman C, Gollin SM, et al. Biology, cytogenetics, and sensitivity to immunological effector cells of new head and neck squamous cell carcinoma lines. Cancer Res 1989;49:5167-5175.
27. Maestro R, Gasparotto D, Vukosavljevic T, Barzan L, Sulfaro S, Boiocchi M. Three discrete regions of deletion at 3p in head and neck cancers. Cancer Res 1993;53:5775-5779.
28. Whang-Peng J, Kao-Shan CS, Lee EC, et al. Specific chromosome defect associated with human small-cell lung cancer; deletion 3p(14-23). Science 1982;215:181-182.
29. Gollin SM. Chromosomal alterations in squamous cell carcinomas of the head and neck: window to the biology of disease. Head Neck 2001;23:238-253.
30. Virgilio L, Shuster M, Gollin SM, et al. FHIT gene alterations in head and neck squamous cell carcinomas. Proc Natl Acad Sci U S A 1996;93:9770-9775.
31. Cowan JM, Beckett MA, Ahmed-Swan S, Weichselbaum RR. Cytogenetic evidence of the multistep origin of head and neck squamous cell carcinomas. J Natl Cancer Inst 1992;84:793-797.
32. Muller D, Millon R, Lidereau R, et al. Frequent amplification of 11q13 DNA markers is associated with lymph node involvement in human head and neck squamous cell carcinomas. Eur J Cancer B Oral Oncol 1994;30:113-120.
33. Rodrigo JP, Suarez C, Gonzalez MV, et al. Variability of genetic alterations in different sites of head and neck cancer. Laryngoscope 2001;111:1297-1301.
34. Meredith SD, Levine PA, Burns JA, et al. Chromosome 11q13 amplification in head and neck squamous cell carcinoma. Association with poor prognosis. Arch Otolaryngol Head Neck Surg 1995;121:790-794.
35. Muller D, Millon R, Veiten M, et al. Amplification of 11q13 DNA markers in head and neck squamous cell carcinomas: correlation with clinical outcome. Eur J Cancer 1997;33:2203-2210.
36. Namazie A, Alavi S, Olopade OI, et al. Cyclin D1 amplification and p16(MTS1/CDK4I) deletion correlate with poor prognosis in head and neck tumors. Laryngoscope 2002;112:472-481.
37. Patel AM, Incognito LS, Schechter GL, Wasilenko WJ, Somers K D. Amplification and expression of EMS-1 (cortactin) in head and neck squamous cell carcinoma cell lines. Oncogene 1996;12:31-35.
38. Huang X, Gollin SM, Raja S, Godfrey TE. High-resolution mapping of the 11q13 amplicon and identification of a gene, TAOS1, that is amplified and overexpressed in oral cancer cells. Proc Natl Acad Sci U S A 2002;99:11369-11374.
39. Gollin SM. Mechanisms leading to chromosomal instability. Semin Cancer Biol 2005;15:33-42.
40. Reshmi SC, Saunders WS, Kudla DM, Ragin CR, Gollin SM. Chromosomal instability and marker chromosome evolution in oral squamous cell carcinoma. Genes Chromosomes Cancer 2004;41:38-46.
41. Saunders WS, Shuster M, Huang X, et al. Chromosomal instability and cytoskeletal defects in oral cancer cells. Proc Natl Acad Sci U S A 2000;97:303-308.
42. Freshney RI. Culture of animal cells. New York: Wiley-Liss; 1994. pp 279-282.
43. Pekkola-Heino K, Joensuu H, Klemi P, Grenman R. Relation of DNA ploidy and proliferation rate to radiation sensitivity in squamous carcinoma cell lines. Arch Otolaryngol Head Neck Surg 1994;120:750-754.
44. Dawson M. Initiation and maintenance of cultures. In: Butler M, Dawson M, editors. Cell culture. Oxford: BIOS Scientific Publishers; 1992. p 35.
45. Pantelouris E. Absence of thymus in a mouse mutant. Nature 1968;217:270, 271.
46. Rygaard J, Povlsen C. Heterotransplantation of a human malignant tumour to 'nude' mice. Acta Pathol Micobiol Scand 1969;77:758-760.
47. Povlsen C, Rygaard J. Heterotransplantation of human epidermoid carcinomas to the mouse mutant nude. Acta Pathol Microbiol Scand 1972;80:713-717.
48. Braakhuis B, Sneeuwloper G, Snow G. The potential of the nude mouse xenograft model for the study of head and neck cancer. Arch Otorhinolaryngol 1984;239:69-79.
49. Immunodeficient model selection: choosing a nude, seid or Rag1 strain. JAX Communication 2000:1-4.
50. Gorelik E, Herberman R. Role of natural killer (NK) cells in the control of tumor growth and metastatic spread. In: Herberman R, editor. Cancer immunology: innovative approaches to therapy. New York: Kluwer Academic Publishers; 1986. pp 151-176.
51. Clarke R. Human tumours in animal hosts. In: Alison M, editor. Cancer handbook. New York: Wiley; 2005. pp 913-922.
52. Kelland LR. Of mice and men: values and liabilities of the athymic nude mouse model in anticancer drug development. Eur J Cancer 2004;40:827-836.
53. Sharkey FE, Fogh J. Metastasis of human tumors in athymic nude mice. Int J Cancer 1979;24:733-738.
54. Sordat M, Merenda C, Carrel S, Invasive growth and dissemination of human solid tumors and malignant cell lines grafted subcutaneously to newborn nude mice, in Proceedings of Second Workshop on Nude Mice. Tokyo (1977)313-325.
55. Dinesman A, Haughey B, Gates GA, Aufdemorte T, Von Hoff DD. Development of a new in vivo model for head and neck cancer. Otolaryngol Head Neck Surg 1990;103(5 Pt 1):766-774.
56. O'Malley BW Jr, Cope KA, Johnson CS, Schwartz MR. A new immunocompetent murine model for oral cancer. Arch Otolaryngol Head Neck Surg 1997;123:20-24.
57. Brooks PC, Montgomery AM, Rosenfeld M, et al. Integrin α v β 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 1994;79:1157-1164.
58. Fukai F, Mashimo M, Akiyama K, Goto T, Tanuma S, Katayama T. Modulation of apoptotic cell death by extracellular matrix proteins and a fibronectin-derived antiadhesive peptide. Exp Cell Res 1998;242:92-99.
59. Kerr JS, Wexler RS, Mousa SA, et al. Novel small molecule α v integrin antagonists: comparative anti-cancer efficacy with known angiogenesis inhibitors. Anticancer Res 1999;19(2A):959-968.
60. Liu W, Ahmad SA, Reinmuth, N, et al. Endothelial cell survival and apoptosis in the tumor vasculature. Apoptosis 2000;5:323-328.
61. Mitjans F, Meyer T, Fittschen C, et al. In vivo therapy of malignant melanoma by means of antagonists of αv integrins. Int J Cancer 2000;87:716-723.
62. Grossmann J. Molecular mechanisms of "detachment-induced apoptosis-Anoikis". Apoptosis 2002;7:247-260.
63. Grenman R, Burk D, Virolainen E, et al. Clonogenic cell assay for anchorage-dependent squamous carcinoma cell lines using limiting dilution. Int J Cancer 1989;44:131-136.
64. Coleman SC, Stewart ZA, Day TA, Netterville JL, Burkey BB, Pietenpol JA. Analysis of cell-cycle checkpoint pathways in head and neck cancer cell lines: implications for therapeutic strategies. Arch Otolaryngol Head Neck Surg 2002;128:167-176.
65. Rupniak HT, Rowlatt C, Lane EB, et al. Characteristics of four new human cell lines derived from squamous cell carcinomas of the head and neck. J Natl Cancer Inst 1985;75:621-635.
66. Freshney RI. Culture of animal cells, 3rd ed. New York: Wiley-Liss; 1994. pp 71-103.
67. Bjerkvig R. Spheroid culture in cancer research. Boca Raton: CRC Press; 1992. pp 3-18.
68. Carlsson J, Nilsson K, Westermark B, et al. Formation and growth of multicellular spheroids of human origin. Int J Cancer 1983;31:523-533.
69. Durand RE. Multicell spheroids as a model for cell kinetic studies. Cell Tissue Kinet 1990;23:141-159.
70. Franko AJ, Sutherland RM. Oxygen diffusion distance and development of necrosis in multicell spheroids. Radiat Res 1979;79:439-453.
71. Freyer JP. Role of necrosis in regulating the growth saturation of multicellular spheroids. Cancer Res 1988;48:2432-2439.
72. Griffon G, Marchal C, Merlin JL, Marchal S, Parache RM, Bey P. Radiosensitivity of multicellular tumour spheroids obtained from human ovarian cancers. Eur J Cancer 1995;31A:85-91.
73. Schwachofer JH, Acker H, Crooijmans RP, et al. Oxygen tensions in two human tumor cell lines grown and irradiated as multicellular spheroids. Anticancer Res 1991;11:273-279.
74. Sutherland R. Cell and environment interations in tumor microregion: the multicell spheroid model. Science 1988;240:177-184.
75. Sutherland RM, Eddy HA, Bareham B, Reich K, Vanantwerp D. Resistance to adriamycin in multicellular spheroids. Int J Radiat Oncol Biol Phys 1979;5:1225-1230.
76. Moscona AA. Cell suspension from organ rudiments of chick embryos. Exp Cell Res 1952;3:535-539.
77. Yuhas J, Martinez A, Ladman A. A simplified methods for the production and growth of multicellular tumor spheroids. Cancer Res 1977;37:3639-3643.
78. Jetten AM, Kim JS, Sacks PG, et al. Inhibition of growth and squamous-cell differentiation markers in cultured human head and neck squamous carcinoma cells by β-all-trans retinoic acid. Int J Cancer 1990;45:195-202.
79. Tupper J, Greco O, Tozer GM, Dachs GU. Analysis of the horseradish peroxidase/indole-3-acetic acid combination in a three-dimensional tumor model. Cancer Gene Ther 2004;11:508-513.
80. Schwachofer JH, Crooijmans RP, Hoogenhout J, Kal HB, Theeuwes AG. Effectiveness of cis-platin and carboplatin in the chemotherapy of squamous cell carcinoma grown as multicellular spheroids. Anticancer Res 1990;10:805-811.
81. Schwachofer JH, Crooijmans RP, van Gasteren J, Hoogenhout J, Jerusalem CR, Kal HB. Sublethal damage repair and radiosensitivity of human squamous cell carcinoma cells grown with different culture techniques. Br J Radiol 1989;62:1084-1088.
82. Griffon-Etienne G, Merlin JL, Marchai C. In vitro evaluation of Taxol combined with radiations in human squamous cell carcinoma spheroids. Cancer Lett 1996;109:23-32.
83. Sturgis EM, Sacks PG, Masui H, Mendelsohn J, Schantz SP. Effects of antiepidermal growth factor receptor antibody 528 on the proliferation and differentiation of head and neck cancer. Otolaryngol Head Neck Surg 1994;111:633-643.
84. Chew EC, King WW, Hou HJ, Yam HF. Establishment and characterization of two new cell lines derived from squamous cell carcinoma of the tongue in Chinese patients. Anticancer Res 1992;121:627-633.
85. Bjerkvig R. Spheroid culture in cancer research. Boca Raton: CRC Press; 1992. pp 41-58.
86. Shapiro J, Shapiro W. The subpopulations and isolated cell types of freshly resected high grade human gliomas: their influence on the tumor's evolution in vivo and behavior and therapy in vitro. Cancer Metastasis Rev 1985;4:107-124.
87. Worsham MJ, Wolman SR, Carey TE, Zarbo RJ, Benninger MS, Van Dyke DL. Chromosomal aberrations identified in culture of squamous carcinomas are confirmed by fluorescence in situ hybridisation. Mol Pathol 1999;52:42-46.
88. Ragin CC, Reshmi SC, Gollin SM. Mapping and analysis of HPV16 integration sites in a head and neck cancer cell line. Int J Cancer 2004;110:701-709.
89. Carlsson J, Nederman T. Tumor spheroid technology in cancer therapy research. Eur J Cancer Clin Oncol 1989;25:1127-1133.
90. Durand R. Variable radiobiological responses of spheroids. Radiat Res 1980;81:85-99.
91. Mueller-Klieser W. Multicellular spheroids. A review on cellular aggregates in cancer research. J Cancer Res Clin Oncol 1987;113:101-122.
92. Mederman T. Growth of tumor cells as multicellular spheroids and antitumor drug evaluation. In: Dendy PP, Hall BT, editors. Human tumor drug testing in vitro. London: Academic Press; 1983. p 147.
93. Sutherland R. Importance of critical metabolites and cellular interactions in the biology of microregions of tumors. Cancer 1986;58:1668-1680.
94. Sutherland R, Durand R. Radiation response of multicell spheroids-an in vitro tumor model. Curr Top Radiat Res Q 1976;11:87-139.
95. Jones AC, Stratford IJ, Wilson PA, Peckham MJ. In vitro cytotoxic drug sensitivity testing of human tumour xenografts grown as multicellular tumour spheroids. Br J Cancer 1982;46:870-879.